Performing an Ethnobridging trial during early clinical development can potentially save your organization time and money, but effective participant recruitment is critical. Here are some strategies for recruiting for your Ethnobridging clinical trials.
Leveraging Regional Diversity within an Area
The primary distinguishing factor in Ethnobridging clinical trials is recruiting the target population in North America or Europe. For example, the clinical trial might have Japanese participants, despite taking place in Los Angeles instead of Tokyo. A superior early phase study will be in an area with regional population diversity, providing researchers access to diverse populations. This is often in major cities with major transit hubs and ports. Study location selection can significantly impact how quickly your team can identify and recruit a sufficient number of participants.
Utilizing Bilingual Recruitment Coordinators
Employing specialized multilingual recruitment staff who understand the participants’ culture is vital for recruiting. Speaking the same language as the participants can help ease tensions and fears in potential participants, making it easier for participants to communicate any questions or concerns they might have. Employing multilingual staff in other departments for these same reasons mentioned could be essential for participant retention throughout their involvement in the clinical study.
Educating Participants
Educating the target community and potential participants about clinical trials can be crucial when forming a database for Ethnobridging trials. For example, continuous communication and education of target populations may be required. Your defined populations might be especially cautious, taking the time to learn and analyze your clinical trial experience before deciding to join the study. Site recruitment coordinators should engage in direct conversations with the target population, providing additional information during calls or other touchpoints. You never want to leave any questions unanswered, and providing as much information as possible could be the key to improving recruitment and retention numbers.
Allowing for Flexible Schedules
Many participants have full-time jobs or class schedules. This can present scheduling concerns, especially across the entire participant base, as participants might have prior obligations you must work around. Flexible scheduling of study visits while staying within the parameters of the study helps each participant coordinate their time effectively, therefore increasing recruitment and retention. Especially for trials with lengthy overnight stays in Phase 1 clinical trial units, it is important to carefully plot out study timelines to maximize participant recruitment. Otherwise, visits may need to be rescheduled, potentially delaying the study. Other accommodations, such as transportation and meals tailored to the target population, should also be considered.
Focusing on Community Outreach and Advertisements
A database and a stream of new potential participants are needed to perform Ethnobridging studies on a continuous basis. Community outreach and advertisements through multiple channels and grassroots recruitment strategies can help your organization connect with people who might become participants. Many organizations have found success partnering with community leaders and local businesses to establish credibility within the community. It can also help build a database of potential future participants, enabling faster recruitment in future clinical trials.
About Altasciences
Altasciences is a mid-size CRO/CDMO offering pharmaceutical and biotechnology companies a proven, flexible, full-service approach to preclinical and clinical pharmacology studies, including program management, medical writing, biostatistics, clinical monitoring, data management, formulation, manufacturing, and analytical services, all customizable to specific sponsor requirements. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences ensures the design and conduct of first in human clinical trials and early efficacy studies generate the data that meets the sponsor’s objectives, leveraging preclinical data in the design of the programs that move the drug candidate to proof of concept. Bringing full-service solutions to sponsors, Altasciences provides access to essential resources for early clinical development, including their 250,000-square-foot clinical pharmacology units (CPUs) with over 580 beds for Phase 1 clinical trials. Complete with state-of-the-art bioanalytical laboratories, Altasciences is also recognized as an industry leader in Asian Ethnobridging clinical studies, specifically with Japanese participants.
Partner with Altasciences for an Ethnobridging clinical trial at https://www.altasciences.com/
Original Source: https://bit.ly/3axGiX1
